Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

NCT07509151 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV

Interventions

DRUG: Surovatamig

Sponsor

AstraZeneca

Collaborators

[object Object]